PureTech ’s Vor Biopharma raises $42M for blood cancer drugs

Boston biotech Vor Biopharma, a company whose science is based on one of the world ’s best-known cancer doctors, this morning announced that it received a $42 million Series A round of investment led by 5AM Ventures and RA Capital Management. Other investors in the startup, which was co-founded by Boston-based PureTech Health, include Johnson& Johnson Innovation, Novartis Institutes for BioMedical Research and Osage University Partners. PureTech Health, which also contributed to the latest round, …
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news